etc-1002 and Thrombosis

etc-1002 has been researched along with Thrombosis* in 1 studies

Reviews

1 review(s) available for etc-1002 and Thrombosis

ArticleYear
Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology.
    Vascular pharmacology, 2023, Volume: 148

    The clinical benefit of LDL cholesterol (LDL-C) lowering for cardiovascular disease prevention is well documented. This paper from the Italian Study Group on Atherosclerosis, Thrombosis and Vascular Biology summarizes current recommendations for treatment of hypercholesterolemia, barriers to lipid-lowering therapy implementation and tips to overcome them, as well as available evidence on the efficacy and safety of bempedoic acid. We also report an updated therapeutic algorithm for pharmacological LDL-C lowering in view of the introduction of bempedoic acid in clinical practice.

    Topics: Atherosclerosis; Biology; Cardiovascular Diseases; Cholesterol, LDL; Consensus; Fatty Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Risk Factors; Thrombosis

2023